Etanercept for the treatment of non-radiographic axial spondyloarthritis

Expert Review of Clinical Immunology
Valeria Rios Rodriguez, Denis Poddubnyy

Abstract

Presently, tumor necrosis factor α antagonist therapy is the only effective alternative treatment to nonsteroidal anti-inflammatory drugs for the entire spectrum of axial spondyloarthritis, including non-radiographic and radiographic (=ankylosing spondylitis) forms. Recently, etanercept has been approved by the European Medicines Agency for the treatment of non-radiographic axial spondyloarthritis, increasing the number of available treatment options for this indication. The latest data on etanercept concerning clinical efficacy and safety in short-term and long-term treatment of patients with non-radiographic axial spondyloarthritis who do not respond to the first-line therapy with non-steroidal anti-inflammatory drugs suggests good efficacy and safety profiles similar to that observed previously in ankylosing spondylitis. This article reviews recent data on the efficacy and safety of etanercept and is focused on the treatment of non-radiographic axial spondyloarthritis. This article will also discuss the role of etanercept in the context of current and developing treatment options.

References

Dec 14, 2002·Annals of the Rheumatic Diseases·H Marzo-OrtegaP Emery
Apr 24, 2003·Clinical Pharmacology and Therapeutics·Howard LeeCarl C Peck
Nov 13, 2003·Arthritis and Rheumatism·John C DavisUNKNOWN Enbrel Ankylosing Spondylitis Study Group
Oct 22, 2004·Journal of Clinical Pharmacology·Honghui ZhouSaeed Fatenejad
Dec 21, 2004·Annals of the Rheumatic Diseases·H HaibelJ Sieper
Aug 30, 2005·Annals of the Rheumatic Diseases·J ZochlingUNKNOWN European League Against Rheumatism
Oct 3, 2006·Arthritis and Rheumatism·Marcos A González-LópezVicente Rodríguez-Valverde
Apr 24, 2007·Lancet·Jürgen Braun, Joachim Sieper
Jul 21, 2007·Seminars in Arthritis and Rheumatism·Beni Grinblat, Morton Scheinberg
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
May 27, 2009·World Journal of Gastroenterology : WJG·Ambrogio OrlandoMario Cottone
Jun 29, 2010·Seminars in Arthritis and Rheumatism·Angelique N Collamer, Daniel F Battafarano
May 5, 2011·Annals of the Rheumatic Diseases·J BraunD van der Heijde
May 5, 2011·Annals of the Rheumatic Diseases·Désirée van der HeijdeUNKNOWN Assessment of SpondyloArthritis international Society
Jun 4, 2011·Thérapie·Lucie JavotUNKNOWN le réseau français des Centres Régionaux de Pharmacovigilance
Nov 20, 2012·The Australasian Journal of Dermatology·Edwina Lamrock, Pam Brown
Dec 13, 2012·Arthritis and Rheumatism·Joachim Sieper, Désirée van der Heijde
Apr 17, 2013·Revista brasileira de reumatologia·Valderílio Feijó Azevedo

❮ Previous
Next ❯

Citations

Mar 16, 2017·Calcified Tissue International·Guillaume CourbonFabienne Coury

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.